Common Contracts
10 similar Underwriting Agreement contracts by Soliton, Inc., Adomani, Inc., True Leaf Medicine International Ltd., VirTra, Inc
EX1A-1 UNDR AGMT 3 d249922dex1a1undragmt.htm EX-1.1 FORM OF UNDERWRITING AGREEMENT ADOMANI, Inc. UNDERWRITING AGREEMENT dated [●], 2017 Boustead Securities, LLC Underwriting Agreement Boustead Securities, LLC, As Representative of the several...Underwriting Agreement • May 5th, 2020 • New York
UNDERWRITING AGREEMENT SOLITON, INC.Underwriting Agreement • August 30th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • California
Soliton, Inc., a Delaware corporation (the “Company”), proposes to issue and sell a minimum of 1,500,000 shares and a maximum of 3,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) to investors deemed acceptable by the Company (the “Investors”) in a public offering pursuant to Regulation A and to engage the several underwriters listed in Schedule A hereto (the “Underwriters”), for whom Boustead Securities, LLC is acting as a representative (the “Representative”) on a best efforts basis. The Underwriters have agreed to act, on a best efforts basis only, as the underwriters in connection with the offering and sale of the Shares (the “Offering”). The Company confirms its agreement with the Underwriters as follows:
UNDERWRITING AGREEMENT SOLITON, INC.Underwriting Agreement • August 10th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • California
Soliton, Inc., a Delaware corporation (the “Company”), proposes to issue and sell a minimum of 1,500,000 shares and a maximum of 3,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) to investors deemed acceptable by the Company (the “Investors”) in a public offering pursuant to Regulation A and to engage the several underwriters listed in Schedule A hereto (the “Underwriters”), for whom Boustead Securities, LLC is acting as a representative (the “Representative”) on a best efforts basis. The Underwriters have agreed to act, on a best efforts basis only, as the underwriters in connection with the offering and sale of the Shares (the “Offering”). The Company confirms its agreement with the Underwriters as follows:
UNDERWRITING AGREEMENT SOLITON, INC.Underwriting Agreement • July 6th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • California
Soliton, Inc., a Delaware corporation (the “Company”), proposes to issue and sell a minimum of 1,500,000 shares and a maximum of 3,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) to investors deemed acceptable by the Company (the “Investors”) in a public offering pursuant to Regulation A and to engage the several underwriters listed in Schedule A hereto (the “Underwriters”), for whom Boustead Securities, LLC is acting as a representative (the “Representative”) on a best efforts basis. The Underwriters have agreed to act, on a best efforts basis only, as the underwriters in connection with the offering and sale of the Shares (the “Offering”). The Company confirms its agreement with the Underwriters as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • December 22nd, 2017 • VirTra, Inc • Services-amusement & recreation services • California
True Leaf Medicine International Ltd. UNDERWRITING AGREEMENT dated November __, 2017 Boustead Securities, LLCUnderwriting Agreement • November 13th, 2017 • True Leaf Medicine International Ltd. • Food and kindred products • California
True Leaf Medicine International Ltd., a Canadian corporation (the "Company"), proposes to issue a maximum of 14,285,715 shares (the "Underwritten Shares") of the Company's common stock, with no par value per share ("Common Stock") for whom Boustead Securities, LLC ("Boustead" or "you") is acting as a representative (the "Representative") for an aggregate of up to $10,000,000 of shares of Common Stock (the "Shares") for sale to investors deemed acceptable by the Company (the "Investors") in an offering pursuant to Regulation A through several underwriters listed in Schedule A hereto (the "Underwriters"),. The Underwriters have agreed to act, on a best efforts basis only, as the Underwriters in connection with the offering and sale of the Shares (the "Offering") as set forth in this Underwriting Agreement (this "Agreement").
True Leaf Medicine International Ltd. UNDERWRITING AGREEMENT dated October __, 2017 Boustead Securities, LLCUnderwriting Agreement • October 26th, 2017 • True Leaf Medicine International Ltd. • Food and kindred products • California
Boustead Securities, LLC, As Representative of the several Underwriters listed in Schedule A hereto c/o Boustead Securities, LLC 6 Venture, Suite 325 Irvine, CA 92618
UNDERWRITING AGREEMENTUnderwriting Agreement • October 17th, 2017 • VirTra, Inc • Services-amusement & recreation services • California
ADOMANI, Inc. UNDERWRITING AGREEMENT dated [●], 2017 Boustead Securities, LLCUnderwriting Agreement • February 13th, 2017 • Adomani, Inc. • Motor vehicle parts & accessories • New York
ADOMANI, Inc. UNDERWRITING AGREEMENT dated [●], 2017 Boustead Securities, LLCUnderwriting Agreement • January 17th, 2017 • Adomani, Inc. • Motor vehicle parts & accessories • New York
